Using a Smoking Cessation Quitline to Promote Lung Cancer Screening.
Objective We assessed whether in-depth messaging delivered via a smoking cessation quitline results in participants: (1) speaking to their physician, or (2) insurance company regarding lung cancer screening (LCS). MethodsEligible participants lived in New York State and met the United States Preventive Services Task Force eligibility criteria for LCS (N = 1000). A randomized trial was conducted among New York State Smokers' Quitline participants to assess the impact of a brochure containing information on risks, benefits, and costs associated with LCS (control group) versus the brochure supplemented with phone-based in-depth messaging (treatment group). ResultsAfter a 4-month telephone survey (N = 431), associations between the study groups were examined for: (1) speaking with a physician regarding LCS, and (2) speaking with an insurance company about LCS coverage. Multivariate logistic regression models adjusted for demographics, insurance status, emphysema/COPD, and past 30-day cigarette use found no significant associations. However, sensitivity analyses among control participants found significant associations, including for speaking with a physician (p < .05) by receipt of the study brochure. Analyses repeated in the treatment group also had statistically significant findings emerge, including for speaking with insurance company (p < .05). ConclusionsThe educational brochure may be an effective and low-cost way to deliver information about LCS.